BCL2 and ovarian cancer: -EGCG potentiates the inhibiting effect of SFN on ovarian cancer cells-EGCG + SFN arrested cells in both G2/M and S phase-EGCG + SFN increased apoptosis in SKOV3TR-ip2 cells, while reducing the expression of hTERT⇒ EGCG and SFN combinationtreatment can inhibit ovarian cancer cells by creating DNA damage through decreasing hTERT and Bcl-2 expression.